ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner
- 24 April 2024
- journal article
- editorial
- Published by Elsevier in Human Pathology
- Vol. 149, 75-76
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experienceHuman Pathology, 2023
- Secondary renal neoplasia following chemotherapy or radiation in pediatric patientsHuman Pathology, 2020
- ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217Laboratory Investigation, 2020
- Responses to Alectinib in ALK-rearranged Papillary Renal Cell CarcinomaEuropean Urology, 2018
- ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsLaboratory Investigation, 2012